Comments
Pharma major Dr Reddy’s Laboratories has launched Lamotrigine extended-release Tablets in the US market.
It is indicated for the treatment of seizures. The tablets are a therapeutic equivalent generic version of Lamictal XR (lamotrigine) which had combined US sales of approximately $300.5 million for the most recent 12 months ended in April 2013, said a release quoting IMS Health.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.